US Healthcare Journal
SEE OTHER BRANDS

Get your fresh news on healthcare and wellness in the United States

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on US Healthcare Journal.

Nextera Healthcare Brings Personalized, 24/7 Direct Primary Care to Colorado Families and Businesses

Nextera Healthcare Brings Personalized, 24/7 Direct Primary Care to Colorado Families and Businesses

New Clinic Model Ensures Prompt Access to Physician Care for Patients and Employers LONGMONT, CO, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- As traditional healthcare systems struggle with growing demand, Nextera Healthcare continues to...

Enanta Pharmaceuticals’ Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Virus

Enanta Pharmaceuticals’ Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Virus

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that the U.S. Food and Drug Administration (FDA) has...

FranDevCo and Water Babies Partner to Make a Big Splash with U.S. Entry

FranDevCo and Water Babies Partner to Make a Big Splash with U.S. Entry

New Collaboration Aims to Provide Millions of American Families with Early Swim Education and Water Safety Instruction CORNELIUS, NC, UNITED STATES, June 11, 2025 /⁨EINPresswire.com⁩/ -- FranDevCo, a national leader in franchise development...

Huntington’s Disease Market to Reach $3.2Bn by 2033 Amid Breakthroughs in Gene-Based Therapies | DataM Intelligence

Huntington’s Disease Market to Reach $3.2Bn by 2033 Amid Breakthroughs in Gene-Based Therapies | DataM Intelligence

Huntington’s Disease market is set to hit $3.2Bn by 2033, propelled by gene therapy innovation, rising awareness, and strong pharma R&D focus. NEW YORK, NY, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- Market Overview: The Huntington’s...

Lancaster Judge Awards State Nearly $800,000 in Medicaid Fraud Case

Lancaster Judge Awards State Nearly $800,000 in Medicaid Fraud Case

A former Lincoln-area provider of Medicaid-funded home and community-based services was ordered to pay the state nearly $800,000 in damages for filing false claims with Nebraska Medicaid. Devon Gibbs and her husband, Christoph Gibbs, were the...

Generic Drugs Market to Surpass $940 Billion by 2033 with Growing Demand for Affordable Medicines | DataM Intelligence

Generic Drugs Market to Surpass $940 Billion by 2033 with Growing Demand for Affordable Medicines | DataM Intelligence

Generic drugs market to hit $942.69B by 2033, driven by cost pressures, patent expirations, and rising chronic disease medication needs. NEW YORK, NY, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- Market Overview: The Generic Drugs Market...

Nebraska Attorney General’s Office Settles with Omaha-Area Home Health Provider for False Medicaid Claims

Nebraska Attorney General’s Office Settles with Omaha-Area Home Health Provider for False Medicaid Claims

Nebraska Attorney General Mike Hilgers announced that his office has settled with ECO Supportive Living, LLC, an Omaha-area provider of home and community-based living services, concerning allegations that one of their contractors caused ECO to...

CGTN: China, U.S. reach principled consensus after in-depth, candid trade talks

CGTN: China, U.S. reach principled consensus after in-depth, candid trade talks

BEIJING, June 11, 2025 (GLOBE NEWSWIRE) -- Following the conclusion of the first meeting of the China-U.S. economic and trade consultation mechanism in London, CGTN published an article summarizing the key outcomes and progress achieved. The...

In Celebration of Father’s Day, Avangrid Recognizes Three Generations of Allen Family Working at Colorado Energy Projects

In Celebration of Father’s Day, Avangrid Recognizes Three Generations of Allen Family Working at Colorado Energy Projects

In celebration of Father’s Day Weekend, Avangrid, Inc., a leading energy company and member of the Iberdrola Group, recognizes three generations of a single family that have worked at the company’s Colorado energy projects over the past two...

Sarasota Medical Products, Inc. Celebrates 15 Years of Innovation, Partnership, and Purpose in Medical Adhesives

Sarasota Medical Products, Inc. Celebrates 15 Years of Innovation, Partnership, and Purpose in Medical Adhesives

Sarasota, Florida, June 13, 2025 (GLOBE NEWSWIRE) -- Sarasota Medical Products, Inc. Sarasota Medical Products, Inc. (SMP), a veteran-owned innovator in the field of medical device adhesives, is proudly celebrating its 15th anniversary. It is a...

Worker Protection from Heat Stress: Now More Than Ever, It's Up to Employers to Do The Right Thing

Worker Protection from Heat Stress: Now More Than Ever, It's Up to Employers to Do The Right Thing

St. Paul, MN, June 13, 2025 (GLOBE NEWSWIRE) -- With federal cost-cutting and deregulation reshaping workplace safety oversight, the responsibility to protect workers from extreme heat is falling squarely on employers. While OSHA’s National...

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints Dupixent also outperformed Xolair in improving such key signs and symptoms as...

TAVA Launches Global Initiative in Zurich to Help European Tech Leaders Win in the U.S. Market

TAVA Launches Global Initiative in Zurich to Help European Tech Leaders Win in the U.S. Market

Transatlantic Venture Association unveils Executive Master Class for European scale-ups, SMEs; first cohort lands in Southern California this October ZüRICH, SWITZERLAND, June 11, 2025 /⁨EINPresswire.com⁩/ -- The Transatlantic Venture Association...

Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues to actively pursue FDA clearance in connection with...

The Next Real Estate Boom: Why Medical Office Buildings Are Outperforming in 2025

The Next Real Estate Boom: Why Medical Office Buildings Are Outperforming in 2025

Discover why Medical Office Buildings are 2025's top real estate performers, offering resilience, strong demand, and stable returns for investors. BETTENDORF, IA, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- The commercial real estate...

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases

SYDNEY, June 11, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical...

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, announced today, through its ENvue Medical Holdings LLC division (“ENvue Medical” or “ENvue”), a new U.S. patent...

U.S. Drone Package Delivery Market Set to Hit $1,080.1 Million by 2030 - Trends, Growth Drivers & Outlook

U.S. Drone Package Delivery Market Set to Hit $1,080.1 Million by 2030 - Trends, Growth Drivers & Outlook

Delray Beach, FL, June 10, 2025 (GLOBE NEWSWIRE) -- The report "US Drone Package Delivery Market by Solution [Platform, Infrastructure, Software, Service], Range (Short, Mid, Long) , Type, Package Size, Duration, End use, Operation Mode and Region...

Parkinson's Disease Market Research Analysis and Forecast, 2025-2035, Featuring Key Players - AbbVie, Merck & Co., GlaxoSmithKline, Novartis, and Teva Pharmaceutical - ResearchAndMarkets.com

Parkinson's Disease Market Research Analysis and Forecast, 2025-2035, Featuring Key Players - AbbVie, Merck & Co., GlaxoSmithKline, Novartis, and Teva Pharmaceutical - ResearchAndMarkets.com

The "Parkinson's Disease Market - A Global and Regional Analysis: Focus on Drug Class, Country, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. As Parkinson's disease is a progressive...

EBC Financial Group Launches over a 100 U.S. ETF CFDs, Strengthening Diversification for Global Clients

EBC Financial Group Launches over a 100 U.S. ETF CFDs, Strengthening Diversification for Global Clients

LONDON, June 11, 2025 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC) has announced the launch of over 100 new U.S.-listed Exchange-Traded Fund (ETF) CFDs, expanding its multi-asset product suite and offering global client's deeper access to...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service